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A standardized protocol for extracting DNA from Aspergillus fumigatus has been proposed by the European
Aspergillus PCR Initiative (EAPCRI). Using meta-regression analysis, the EAPCRI showed certain stages of the
process to be critical to providing a satisfactory analytical sensitivity. The study investigated each step of the
EAPCRI protocol by elimination and monitored the influence on Aspergillus PCR performance.
The European Aspergillus PCR Initiative (EAPCRI) re-
cently published their research evaluating fungal DNA extrac-
tion and Aspergillus PCR amplification techniques (5). The
paper focused on DNA extraction from whole blood with the
aim of providing a standard that could be used to assess clinical
validity and utility to allow its inclusion in future disease-
defining criteria (1). The results showed that the DNA extrac-
tion process was critical to the success of most PCR ampli-
fication systems that performed adequately with similar
analytical sensitivities.
The standardized whole-blood fungal DNA extraction pro-
tocol involved lysis of human blood cells before lysis of the
fungal cell by mechanical disruption and DNA purification,
precipitation, and elution using commercial kits or instru-
ments. Individual steps and parameters in the DNA extraction
process, namely, white cell lysis, fungal lysis by bead beating,
and determination of the elution volume, were shown statisti-
cally to be crucial to its success, whereas other steps, such as
using the entire specimen and red cell lysis, were not critical
but were associated with better assay performance. The focus
of this report is the evaluation of the performance of the
recommended EAPCRI whole-blood DNA extraction proto-
col with stepwise exclusion/modification of individual steps
with the aim of corroborating the critical stages of fungal DNA
extraction and the rationale behind the EAPCRI recommen-
dations.
EDTA-whole blood was spiked with A. fumigatus (ATCC
strain 1022) conidia at two clinically representative fungal bur-
dens (33 conidia/ml and 10 conidia/ml) and then frozen at
80°C. Five replicates of 3 ml EDTA-blood with each fungal
concentration were tested for each extraction variant, and con-
trols were included to monitor interexperimental variation and
possible contamination. The full DNA extraction protocol was
that recommended by the EAPCRI, and on this occasion, the
Roche High Pure template DNA kit was used for final DNA
purification (5). For most methods, DNA was eluted in a final
volume of 60 l, providing DNA eluate concentrations of 8.8
to 88.3 rRNA copies per l, dependent on the fungal burden
and methodology (Table 1). DNA extraction was then per-
formed, with individual steps of the protocol omitted or mod-
ified as described in Table 1. To monitor PCR inhibition, an
internal control (IC), a plasmid containing the capsular trans-
port (CTRA) gene of Neisseria meningitidis, was introduced at
the start of the process that used the High Pure kit. As the IC
was not included from the start, it could not be used to deter-
mine extraction efficiency. The EAPCRI protocol was also
modified to include the additional step of a hot NaOH incu-
bation to help permeabilize the fungal cell wall as previously
described (3). Aspergillus PCR was performed in duplicate by
using the method of White et al., albeit using volumes that
allowed PCR to be performed using 15 l of DNA template in
a final volume of 50 l amplified using the Corbett Rotorgene
3000 system (6). PCR standards were included to monitor
amplification efficiency and maintain interexperimental thresh-
old consistency. The IC PCR used 10 l of DNA template in
a final volume of 20 l, and PCR inhibition was determined by
comparison of the individual threshold cycle (CT) for each
specimen to that of a positive plasmid control.
At the higher fungal burden (33 conidia/ml), only the omis-
sion of bead beating significantly affected Aspergillus PCR de-
tection rates compared to those attained using the EAPCRI
protocol (Table 2). Four modifications affected PCR amplifi-
cation, indicating suboptimal quality and/or quantity of DNA
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as represented by later Aspergillus PCR CT values (Table 2). In
using 1 ml of the 3-ml specimen, the fungal burden potentially
available was reduced from 33 conidia/ml to 11 conidia/ml, a
load almost identical to that of the 3-ml specimen spiked with
10 conidia/ml extracted using the EAPCRI method (Table 1).
CT values for these specimens were also the same (Table 2).
Removal of a bead-beating step reduced the quantity of fungal
DNA extracted, not only affecting reproducibility but also the
Aspergillus PCR CT values. Omission of white cell lysis affected
the IC, indicating the presence of an inhibitor, and without
prior lysis, human DNA survived the extraction, possibly in
DNA concentrations potentially detrimental to PCR amplifi-
cation, although the higher burden was still reproducibly de-
tected. It is postulated that the high fungal DNA concentration
combined with a large Aspergillus PCR volume compared to
those of the IC PCR limited the inhibitory effect. Elution in a
larger volume, 200 l, resulted in a DNA concentration that
was lower than those attained using the EAPCRI method and
is reflected by later CT values in both the Aspergillus PCR and
IC and a slight reduction in Aspergillus PCR reproducibility
(Tables 1 and 2).
At the lower fungal burden (10 conidia/ml), seven modifi-
cations affected Aspergillus PCR performance (Table 2). As
bead beating was so detrimental for the detection of the higher
fungal burden, it was not evaluated at this lower load. Using
less than the entire 3-ml specimen, excluding white cell lysis,
and eluting in volumes of 100 l greatly reduced detection
rates compared to those obtained using the EAPCRI protocol.
Assuming 100% extraction efficiency and elution in 60 l,
using a 15-l template input for PCR incorporates 7.5 (95%
confidence interval [CI], 2.7 to 12.3) A. fumigatus genomes per
reaction, certifying the presence of DNA within each reaction,
whereas elutions in 100-l and 200-l volumes incorporate 4.5
(95% CI, 0.5 to 8.5) and 2.25 (95% CI, 0 to 5.0) genomes per
reaction, respectively, reducing replicate reproducibility.
A reduced detection rate was coupled with later CT values
compared to those obtained with the EAPCRI method, and
four modifications resulted in mean CT values greater than 40
cycles, a threshold that reduces real-time PCR reproducibility
below 100% (4). Later CT values were also seen if red cell lysis
was not done, and this was coupled with a slight reduction in
the detection rate. Again, the IC was affected by the absence of
the white cell lysis step and by the elution of DNA in 200-l
volumes (Table 2).
The removal of one red cell lysis step had no affect on PCR
performance, but in this investigation, the blood was frozen
prior to testing, resulting in the lysis of the red cells. It is likely
that when using fresh blood, two red cell lysis steps are re-
quired. Incorporating incubation with hot NaOH after white
cell lysis did not improve PCR reproducibility or CT values for
either fungal burden. The primary function of a NaOH incu-
bation is to permeabilize the fungal cell wall and, in so doing,
aid downstream lyticase digestion. The use of bead beating
obviates this additional step, though hot alkali treatment may
still be beneficial when testing blood from nonneutropenic
patients, as a greater abundance of white cells may persist
despite attempts at conventional lysis (personal practical expe-
rience).
In conclusion, to improve analytical sensitivity, the EAPCRI
recommends the use of 3 ml EDTA blood specimens, a red
and white cell lysis step, bead beating to lyse the fungal ele-
ment, and elution volumes of less than 100 l. This research
investigating the influence of the individual steps of the
EAPCRI protocol supports the original findings and empha-
sizes their importance at low fungal burdens.
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